Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology.
These guidelines were created to dispel confusion and provide guidance about how the isolation of Helicobacter pylori infection has led to new opportunities and initiatives to improve patient care. The guidelines are designed for practical application in management decisions, but must remain flexible and amenable to change with new information. Updated versions of the recommendations are anticipated. Although it is now clear that H pylori is a major gastrointestinal pathogen, the extent of the clinical consequences posed by this microorganism has yet to be fully defined.
Hunt
R
R
Division of Gastroenterology, McMaster University, Hamilton, Ontario.
Thomson
A B
AB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001944:Breath Tests; D002170:Canada; D004359:Drug Therapy, Combination; D016099:Endoscopy, Gastrointestinal; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D016480:Helicobacter pylori / Q000276:immunology; D006801:Humans
D000900:Anti-Bacterial Agents